cirsimaritin has been researched along with daidzein in 1 studies
| Studies (cirsimaritin) | Trials (cirsimaritin) | Recent Studies (post-2010) (cirsimaritin) | Studies (daidzein) | Trials (daidzein) | Recent Studies (post-2010) (daidzein) |
|---|---|---|---|---|---|
| 49 | 0 | 21 | 1,885 | 136 | 753 |
| Protein | Taxonomy | cirsimaritin (IC50) | daidzein (IC50) |
|---|---|---|---|
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 91.26 | |
| Estrogen receptor | Homo sapiens (human) | 2.97 | |
| Aldehyde dehydrogenase, mitochondrial | Homo sapiens (human) | 9 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 7.3 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.45 | |
| Estrogen receptor beta | Homo sapiens (human) | 1.6568 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, R; Lack, G; Perozzo, R; Rüedi, P; Scapozza, L; Tasdemir, D | 1 |
1 other study(ies) available for cirsimaritin and daidzein
| Article | Year |
|---|---|
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Alcohol Oxidoreductases; Animals; Antimalarials; Catechin; Cells, Cultured; Chloroquine; Drug Resistance; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Fatty Acids; Flavones; Flavonoids; Humans; Hydro-Lyases; Kinetics; Luteolin; Phenols; Plasmodium falciparum; Polyphenols; Structure-Activity Relationship | 2006 |